Certis Oncology Solutions, Inc.
Address: 5626 Oberlin Drive, Suite 110, San Diego, California, United States, 92121
Website: https://www.certisoncology.com/
About Certis Oncology Solutions
Certis Oncology is a life science technology company committed to realizing the promise of precision oncology. The company’s product is Oncology Intelligence® — highly predictive therapeutic response data derived from advanced models of cancer. We partner with physician-scientists and industry researchers to expand access to precision oncology and close the problematic translation gap between preclinical studies and clinical trials.
About CertisAI Predictive Oncology Intelligence™
CertisAI™ is the first and only patented, commercially available, validated AI/ML platform that predicts therapeutic efficacy by identifying complex gene expression signatures that correlate with drug response. The platform is designed to assist pharmaceutical researchers to develop and clinicians to identify new treatment options for specific cancers based on a tumor’s unique gene expression profile.
About CertisOI Assistant™
CertisOI Assistant is a natural language intermediary for accessing the genomic and drug sensitivity characterization data associated with thousands of cancer research models, including Certis’ patient-derived xenograft (PDX) models as well as public cancer cell lines from the Cancer Cell Line Encycolopedia (CCLE). It leverages the company’s proprietary CertisAI Predictive Oncology Intelligence™ platform to quickly provide researchers with unparalleled insights into cancer models and drug response, bringing greater precision to early drug development decisions.
